Jun 2026 (Q4 FY26) — Aug 6, 2026
Covista Q4 FY26 — Exceeds Targets, Launches "Purpose at Scale" Strategy
Read the full callCovista (CVSA) earnings
- Jun 2026
- Jun 2026 (Q4 FY26)
- Jun 2026
Covista earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 501 | +9.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 19.0 | +2.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 71.7 | +32.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$127.24 −1.73% · −$2.24
Performance −15.0% 1Y
1Y: $149.73 on 14 Oct 2025 → $127.24. High $153.98 (28 Oct 2025), low $89.36 (24 Nov 2025).
- Previous close
- $129.48
- 52-week range
- $89.36 – $153.98
- One year
- −14.39%
Overview
- Symbol
- CVSA
- Sector
- Consumer Staples
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q3 FY26) — May 7, 2026
Covista Q3 FY26 — Chamberlain Returns to Growth, Raised Full-Year Guidance
Read the full callEvery analysed call
Covista earnings calls (CVSA)
Financials
What the filings say
Net profit, year on year: +32% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 417 | 448 | 466 | 457 | 462 | 503 | 487 | 501 |
| Expenses | 347 | 344 | 376 | 380 | 377 | 392 | 396 | 406 |
| Operating profit | 70 | 104 | 91 | 77 | 85 | 111 | 91 | 95 |
| Operating margin | 16.8% | 23.2% | 19.4% | 16.8% | 18.5% | 22.1% | 18.8% | 19.0% |
| Interest | 14 | 14 | 13 | 11 | 11 | 11 | 14 | 10 |
| Profit before tax | 58 | 92 | 79 | 69 | 77 | 102 | 78 | 88 |
| Tax rate | 20.8% | 22.8% | 23.4% | 20.6% | 20.6% | 25.3% | 25.6% | 18.4% |
| Net profit | 46 | 76 | 61 | 54 | 62 | 76 | 42 | 72 |
| EPS ($ per share) | 1.22 | 2.03 | 1.64 | — | 1.71 | 2.14 | 1.21 | — |
| Line item | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | 2,013 | 1,928 | 2,005 | 2,310 | 2,404 | 2,541 | 2,778 | 3,029 |
| Total liabilities | 842 | 915 | 1,782 | 1,539 | 1,353 | 1,372 | 1,319 | 1,567 |
| Fixed assets | 283 | 286 | 284 | 290 | 245 | 249 | 256 | 303 |
| Investments | 9 | 9 | — | — | — | — | — | — |
| Total assets | 2,243 | 2,258 | 3,085 | 3,030 | 2,811 | 2,741 | 2,752 | 3,013 |
| Line item | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 205 | 108 | 192 | 11 | 192 | 296 | 338 | 470 |
| Cash from investing | -214 | 383 | -57 | -552 | 24 | -48 | -42 | -84 |
| Cash from financing | -138 | -256 | 676 | -424 | -289 | -302 | -316 | -180 |
| Net cash flow | -144 | 201 | 813 | -966 | -73 | -54 | -20 | 207 |
| Capital expenditure | -58 | -40 | -40 | -31 | -26 | -49 | -50 | -78 |
| Free cash flow | 147 | 68 | 152 | -20 | 166 | 247 | 288 | 393 |
CVSA revenue by segment
| Segment | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Walden University | — | — | — | — | — | — | 38% | 42% | — |
| Chamberlain University | — | — | — | — | — | — | 40% | 38% | — |
| Medical and Veterinary | — | — | — | — | — | — | 21% | 20% | — |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
CVSA operating KPIs by quarter
| KPI | Mar 2026 Q3 FY26 | Jun 2026 Q4 FY26 | Change vs prior quarter |
|---|---|---|---|
| Total student enrollment Walden | 54.474KTotal student enrollment grew 12.3% to 54,474 students joining Chamberlain and also setting a record this quarter and marking Walden's 11th consecutive quarter of total enrollment growth.Source: earnings call transcript | <55KTotal student enrollment was up 14% to nearly 55,000 students, our 12th consecutive quarter of growth and the highest total enrollment in Walden's history with strength across health care and non-health care programs.Source: earnings call transcript | — |
| Total student enrollment Medical and Veterinary | 5,344Total student enrollment increased 4.1% to 5,344 students with growth in both our medical and veterinary programs.Source: earnings call transcript | 5,100+Total student enrollment was up 7.3% to over 5,100 students, led by medical with new enrollment accelerating at both Med and Vet.Source: earnings call transcript | — |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Revenue by region
Q4 FY2026 · share of revenue
- Domestic Operations 80%
As CVSA cuts its regions in its filings; they can nest, so they need not add to 100%.
Insider filings
90 filings between Nov 4, 2025 and Oct 9, 2026.
Open market
decisions to buy or sellPurchases
$3.89M
6 purchases by 2 insiders
Sales
$10.32M
17 sales by 5 insiders
100% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 30
- Award — granted as compensation
- 35
- Tax withheld — shares kept back by the company to cover tax
Also filed: 2 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Beard, Stephen W. | — | $5.02M | Oct 9, 2026 |
| MALAFRONTE MICHAEL W | $3.84M | — | Mar 11, 2026 |
| BECK DOUGLAS G. | — | $2.52M | Aug 7, 2026 |
| Phelan Robert J. | — | $2.28M | Aug 7, 2026 |
| Cox Karen Sue | — | $249.0K | May 8, 2026 |
| Gangadharan Manjunath | — | $247.2K | Aug 27, 2026 |
| Phelan Kenneth J | $49.9K | — | Nov 5, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Beard, Stephen W. Chairman & CEO | Sale 10b5-1 plan | 4,667 | $610.3K |
| Oct 8, 2026 | Beard, Stephen W. Chairman & CEO | Sale 10b5-1 plan | 3,639 | $474.4K |
| Aug 31, 2026 | MALAFRONTE MICHAEL W Director | Gift | 2,500 | $0 |
| Aug 27, 2026 | Gangadharan Manjunath VP, Chief Accounting Officer | Sale 10b5-1 plan | 1,802 | $247.2K |
| Aug 23, 2026 | Beard, Stephen W. Chairman & CEO | Tax withheld | 9,621 | $1.27M |
| Aug 23, 2026 | Gangadharan Manjunath VP, Chief Accounting Officer | Award | 1,500 | $198.5K |
| Aug 23, 2026 | Beard, Stephen W. Chairman & CEO | Award | 53,144 | $7.03M |
| Aug 23, 2026 | Phelan Robert J. Chief Financial Officer | Tax withheld | 4,466 | $591.1K |
| Aug 23, 2026 | Beard, Stephen W. Chairman & CEO | Tax withheld | 33,633 | $4.45M |
| Aug 23, 2026 | Gangadharan Manjunath VP, Chief Accounting Officer | Tax withheld | 188 | $24.9K |
| Aug 23, 2026 | Betz Michael Pres. Walden University & CDO | Award | 5,124 | $678.2K |
| Aug 23, 2026 | Beard, Stephen W. Chairman & CEO | Tax withheld | 23,543 | $3.12M |
| Aug 23, 2026 | BECK DOUGLAS G. SVP, GC, Corp. Sec & ISS | Award | 4,242 | $561.4K |
| Aug 23, 2026 | Gangadharan Manjunath VP, Chief Accounting Officer | Tax withheld | 440 | $58.2K |
| Aug 23, 2026 | BECK DOUGLAS G. SVP, GC, Corp. Sec & ISS | Award | 6,060 | $802.0K |
| Aug 23, 2026 | Phelan Robert J. Chief Financial Officer | Tax withheld | 3,126 | $413.7K |
| Aug 23, 2026 | Phelan Robert J. Chief Financial Officer | Award | 7,056 | $933.9K |
| Aug 23, 2026 | Phelan Robert J. Chief Financial Officer | Award | 10,080 | $1.33M |
| Aug 23, 2026 | BECK DOUGLAS G. SVP, GC, Corp. Sec & ISS | Tax withheld | 2,746 | $363.4K |
| Aug 23, 2026 | Betz Michael Pres. Walden University & CDO | Tax withheld | 945 | $125.1K |
| Aug 23, 2026 | Betz Michael Pres. Walden University & CDO | Award | 7,320 | $968.8K |
| Aug 23, 2026 | Betz Michael Pres. Walden University & CDO | Tax withheld | 3,302 | $437.0K |
| Aug 23, 2026 | Gangadharan Manjunath VP, Chief Accounting Officer | Award | 1,050 | $139.0K |
| Aug 23, 2026 | Betz Michael Pres. Walden University & CDO | Tax withheld | 2,311 | $305.9K |
| Aug 23, 2026 | Gangadharan Manjunath VP, Chief Accounting Officer | Tax withheld | 308 | $40.8K |
| Aug 23, 2026 | BECK DOUGLAS G. SVP, GC, Corp. Sec & ISS | Tax withheld | 784 | $103.8K |
| Aug 23, 2026 | BECK DOUGLAS G. SVP, GC, Corp. Sec & ISS | Tax withheld | 1,922 | $254.4K |
| Aug 23, 2026 | Phelan Robert J. Chief Financial Officer | Tax withheld | 1,279 | $169.3K |
| Aug 23, 2026 | Beard, Stephen W. Chairman & CEO | Award | 75,920 | $10.05M |
| Aug 11, 2026 | Beard, Stephen W. Chairman & CEO | Sale 10b5-1 plan | 3,545 | $462.1K |
| Aug 7, 2026 | Phelan Robert J. Chief Financial Officer | Sale 10b5-1 plan | 2,186 | $295.4K |
| Aug 7, 2026 | BECK DOUGLAS G. SVP, GC, Corp. Sec & ISS | Sale 10b5-1 plan | 4,526 | $614.7K |
| Jul 15, 2026 | Manning Amelia President, Chamberlain Univ. | Award | 4,317 | $500.0K |
| Jul 13, 2026 | Beard, Stephen W. Chairman & CEO | Sale 10b5-1 plan | 5,291 | $702.4K |
| Jul 8, 2026 | Phelan Robert J. Chief Financial Officer | Sale 10b5-1 plan | 2,414 | $326.8K |
| Jul 8, 2026 | BECK DOUGLAS G. SVP, GC, Corp. Sec & ISS | Sale 10b5-1 plan | 2,439 | $330.1K |
| Jul 7, 2026 | BECK DOUGLAS G. SVP, GC, Corp. Sec & ISS | Sale 10b5-1 plan | 2,650 | $358.8K |
| Jul 7, 2026 | Phelan Robert J. Chief Financial Officer | Sale 10b5-1 plan | 2,900 | $392.7K |
| Jun 11, 2026 | Beard, Stephen W. Chairman & CEO | Sale 10b5-1 plan | 2,529 | $330.8K |
| Jun 10, 2026 | Beard, Stephen W. Chairman & CEO | Sale 10b5-1 plan | 2,762 | $359.4K |
| May 18, 2026 | Gangadharan Manjunath VP, Chief Accounting Officer | Tax withheld | 426 | $54.5K |
| May 8, 2026 | Beard, Stephen W. Chairman & CEO | Sale 10b5-1 plan | 15,874 | $2.08M |
| May 8, 2026 | Phelan Robert J. Chief Financial Officer | Sale 10b5-1 plan | 10,000 | $1.26M |
| May 8, 2026 | BECK DOUGLAS G. SVP, GC, Corp. Sec & ISS | Sale 10b5-1 plan | 9,615 | $1.22M |
| May 8, 2026 | Cox Karen Sue President, Chamberlain Univ. | Sale 10b5-1 plan | 2,000 | $249.0K |
| Apr 15, 2026 | Liles Scott President, Medical and Vet | Tax withheld | 448 | $50.4K |
| Mar 11, 2026 | MALAFRONTE MICHAEL W Director | Purchase | 8,890 | $897.3K |
| Mar 10, 2026 | MALAFRONTE MICHAEL W Director | Purchase | 15,305 | $1.54M |
| Mar 10, 2026 | MALAFRONTE MICHAEL W Director | Purchase | 11,841 | $1.19M |
| Mar 3, 2026 | MALAFRONTE MICHAEL W Director | Purchase | 1,200 | $117.6K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Covista Inc.
Free account. Everything above stays public.
Write why you follow Covista Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading